ResearcherUniversity of Milano-BicoccaActive in the last 2 years
Luca Vittorio Gianotti
Matched on ORCID iD 0000-0001-7335-8394; OpenAlex author ID A5013102708. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 44
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 4 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 9
- Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume. Co-author DOI 10.1007/s13304-026-02813-5↗
- Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment. First author DOI 10.1016/j.ejso.2022.12.006↗
- Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective,… Co-author DOI 10.3389/fnut.2023.1065294↗
- Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving surgery for pancreatic cancer. Last author DOI 10.3389/fnut.2023.1118616↗
- Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a r… Co-author DOI 10.3389/fnut.2023.1212436↗
- Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectabili… Co-author DOI 10.1097/as9.0000000000000087↗
- Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-020-08515-5↗
- Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2018.0979↗
- The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis. Co-author DOI 10.1016/j.ejso.2016.02.003↗
Closest collaborators
The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roberto Salvia · 7 shared papers, 2016–2023 · strength 0.82
- Paper Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving sur… DOI 10.3389/fnut.2023.1118616↗
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Marta Sandini · 7 shared papers, 2016–2023 · strength 0.78
- Paper Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving sur… DOI 10.3389/fnut.2023.1118616↗
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Salvatore Paiella · 7 shared papers, 2016–2023 · strength 0.78
- Paper Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving sur… DOI 10.3389/fnut.2023.1118616↗
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Alessandro Zerbi · 5 shared papers, 2021–2023 · strength 0.66
- Paper Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving sur… DOI 10.3389/fnut.2023.1118616↗
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Claudio Bassi · 6 shared papers, 2016–2023 · strength 0.63
- Paper Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving sur… DOI 10.3389/fnut.2023.1118616↗
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Giuseppe Malleo · 5 shared papers, 2020–2023 · strength 0.59
- Paper Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving sur… DOI 10.3389/fnut.2023.1118616↗
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Giovanni Luigi Capretti · 4 shared papers, 2021–2023 · strength 0.51
- Paper Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving sur… DOI 10.3389/fnut.2023.1118616↗
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Riccardo Casadei · 3 shared papers, 2021–2023 · strength 0.36
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Paper Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Int… DOI 10.1097/as9.0000000000000087↗
- Erica Secchettin · 3 shared papers, 2020–2023 · strength 0.35
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Paper Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma. DOI 10.1245/s10434-020-08515-5↗
- Ilaria Trestini · 3 shared papers, 2020–2023 · strength 0.35
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Paper Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma. DOI 10.1245/s10434-020-08515-5↗
- Michèle Milella · 3 shared papers, 2020–2023 · strength 0.35
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Paper Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma. DOI 10.1245/s10434-020-08515-5↗
- Matteo De Pastena · 2 shared papers, 2023 · strength 0.26
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Darío Gregori · 2 shared papers, 2023 · strength 0.26
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Carlo Ingaldi · 2 shared papers, 2023 · strength 0.26
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Giulia Angela Zamboni · 2 shared papers, 2023 · strength 0.26
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Gennaro Nappo · 2 shared papers, 2023 · strength 0.26
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Laura Maggino · 2 shared papers, 2023 · strength 0.26
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Claudio Ricci · 2 shared papers, 2023 · strength 0.26
- Paper Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected aft… DOI 10.3389/fnut.2023.1065294↗
- Paper Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients… DOI 10.3389/fnut.2023.1212436↗
- Raffaele De Luca · 2 shared papers, 2021–2023 · strength 0.24
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Int… DOI 10.1097/as9.0000000000000087↗
- Ugo Boggi · 2 shared papers, 2021–2023 · strength 0.24
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Int… DOI 10.1097/as9.0000000000000087↗
- Massimo Falconi · 2 shared papers, 2021–2023 · strength 0.24
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Int… DOI 10.1097/as9.0000000000000087↗
- Andrea Pietrabissa · 1 shared paper, 2023 · strength 0.15
- Nicolò Pecorelli · 1 shared paper, 2023 · strength 0.15
- Oronzo Brunetti · 1 shared paper, 2023 · strength 0.15
- Riccardo Caccialanza · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.